RecruitingNCT06800586
Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
300 participants
Start Date
Sep 15, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to examine the exposure to atmospheric pollutants in a group of non-smoking patients suffering from lung cancer, chronic obstructive pulmonary disease (COPD), and leukemia. The exposure to atmospheric pollutants will be assessed simultaneously in a group of healthy volunteers. The ultimate goal of the study is to enhance the understanding of the mechanisms by which atmospheric pollutants act, in order to develop new tools that can help halt or at least delay the development of diseases associated with pollution.
Eligibility
Min Age: 18 Years
Inclusion Criteria33
- Patient Cohort to be Recruited at the Department of Pneumology and Respiratory Intensive Care, IRCCS AOU of Bologna:
- Age ≥ 18 years
- Patients with a diagnosis of COPD of any severity (FEV1/FVC \< 0.7 after bronchodilation test)
- Non-smokers according to ISS definition: patients who declare having smoked less than 100 cigarettes (5 packs of 20) in their lifetime and are not currently smokers
- Signature of informed consent
- Healthy Volunteer Cohort to be Recruited at the Department of Pneumology and Respiratory Intensive Care, IRCCS AOU of Bologna:
- Age ≥ 18 years
- Non-smokers according to ISS definition: subjects who declare having smoked less than 100 cigarettes (5 packs of 20) in their lifetime and are not currently smokers
- Absence of comorbidities related to the study (COPD, solid tumors, leukemia) in medical history
- Workers of the IRCCS AOU of Bologna, S. Orsola Polyclinic
- Signature of informed consent
- Patient Cohort to be Recruited at the Department of Medical Oncology, IRCCS AOU of Bologna:
- Age ≥ 18 years
- Patients with a diagnosis of lung neoplasm of any histotype and stage
- Non-smokers according to ISS definition: patients who declare having smoked less than 100 cigarettes (5 packs of 20) in their lifetime and are not currently smokers
- Signature of informed consent
- Healthy Volunteer Cohort to be Recruited at the Department of Medical Oncology, IRCCS AOU of Bologna:
- Age ≥ 18 years
- Non-smokers according to ISS definition: subjects who declare having smoked less than 100 cigarettes (5 packs of 20) in their lifetime and are not currently smokers
- Absence of comorbidities related to the study (COPD, solid tumors, leukemia) in medical history
- Workers of the IRCCS AOU of Bologna, S. Orsola Polyclinic
- Signature of informed consent
- Patient Cohort to be Recruited at the Hematology Department (Hospital-University Company, Policlinico Riuniti di Foggia):
- Age ≥ 18 years
- Non-smokers according to ISS definition: patients who declare having smoked less than 100 cigarettes (5 packs of 20) in their lifetime and are not currently smokers
- Patients with a diagnosis of leukemia of any type
- Signature of informed consent
- Healthy Volunteer Cohort to be Recruited at the Hematology Department (Hospital-University Company, Policlinico Riuniti di Foggia):
- Age ≥ 18 years
- Non-smokers according to ISS definition: subjects who declare having smoked less than 100 cigarettes (5 packs of 20) in their lifetime and are not currently smokers
- Absence of comorbidities related to the study (COPD, solid tumors, leukemia) in medical history
- Workers of the Hospital-University Company, Policlinico Riuniti di Foggia
- Signature of informed consent
Exclusion Criteria15
- Patient Cohort to be Recruited at the Department of Pneumology and Respiratory Intensive Care, IRCCS AOU of Bologna:
- Deficiency of alpha-1 antitrypsin (A1AT)
- Healthy Volunteer Cohort to be Recruited at the Department of Pneumology and Respiratory Intensive Care, IRCCS AOU of Bologna:
- Workers from the Department of Pneumology and Respiratory Intensive Care, IRCCS AOU of Bologna, S. Orsola Polyclinic
- Patient Cohort to be Recruited at the Department of Medical Oncology, IRCCS AOU of Bologna:
- Previous and/or current diagnosis of solid tumors, myelodysplastic syndromes, myeloproliferative neoplasms
- Previous and/or current treatment with antineoplastic agents
- Healthy Volunteer Cohort to be Recruited at the Department of Medical Oncology, IRCCS AOU of Bologna:
- Workers from the Department of Medical Oncology, IRCCS AOU of Bologna, S. Orsola Polyclinic
- Patient Cohort to be Recruited at the Hematology Department (Hospital-University Company, Policlinico Riuniti di Foggia):
- Previous diagnosis of solid tumors, myelodysplastic syndromes, myeloproliferative neoplasms
- Previous treatment with antineoplastic agents (alkylating agents, hydroxyurea, topoisomerase II inhibitors, lenalidomide) -Presence of pre-existing genetic conditions (Fanconi anemia, ataxia- telangiectasia, Down syndrome, xeroderma pigmentosum, Li-Fraumeni syndrome)
- Infection with human immunodeficiency virus (HIV), human T-lymphotropic virus types 1 or 2, or Epstein-Barr virus
- Healthy Volunteer Cohort to be Recruited at the Hematology Department (Hospital-University Company, Policlinico Riuniti di Foggia):
- Workers from the Hematology Department, Hospital-University Company, Policlinico Riuniti di Foggia
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06800586
Related Trials
Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC
NCT071202821 location
Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
NCT069878901 location
Engagement of Veterans With Lung Cancer
NCT072192511 location
Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
NCT069749811 location
Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC
NCT066633061 location